Dynamic changes of estimated glomerular filtration rate are conversely related to triglyceride in non-overweight patients

Table 1 Baseline characteristics of patients

Variables	BMI < 25 (n = 158)	BMI ≥ 25 (n = 44)	Z or χ2	P value
Age (yr)	36.0 (32.0-47.3)	38.0 (32.3-45.8)	-0.098	0.92
Male, n (%)	111 (70.3)	39 (88.6)	6.084	0.01
ALT (U/L)	59.7 (29.3-163.5)	52.6 (36.0-189.6)	-0.684	0.49
AST (U/L)	40.6 (28.2-92.5)	44.0 (25.4-104.3)	-0.222	0.83
TBIL (µmol/L)	14.1 (10.7-20.8)	16.0 (12.3-18.9)	-1.328	0.18
CHOL (mmol/L)	3.9 (3.2-4.4)	3.8 (3.2-4.4)	-0.023	0.98
TG (mmol/L)	0.9 (0.6-1.2)	1.0 (0.7-1.4)	-1.508	0.13
Cr (µmol/L)	69.0 (59.8-81.0)	77.0 (62.0-85.2)	-2.342	0.02
eGFR (mL/(min·1.73 m2)	112.5 (97.0-131.4)	105.9 (96.4.3-133.9)	-0.951	0.18
eGFR categories, n (%)
< 90	22 (13.9)	10 (22.7)
≥ 90	136 (86.0)	34 (77.3)	2.001	0.16
LC, n (%)	27 (17.1)	7 (20.6)	0.034	0.85
Diabetes mellitus, n (%)	4 (2.5)	2 (4.5)	0.484	0.49
Kidney disease, n (%)	1 (0.6)	0 (0)	0.28	0.6
HBV DNA (Log10IU/mL)	5.06 (3.72-6.86)	5.17 (3.2-6.97)	-0.091	0.93
HBeAg, n (%)	112 (70.9)	33 (75.0)	0.288	0.59

Data are presented as proportions, or medians (inter-quartile). The Mann-Whitney U test for quantitative data with non-normal distribution, and Chi-square test for categorical values. BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBil: Total bilirubin; CHOL: Total cholesterol; TG: Triglycerides; Cr: Creatinine; eGFR: Estimate glomerular filtration rate; LC: Liver cirrhosis; HBeAg: Hepatitis B surface antigen.